These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23116313)
21. Curcumin: a boon to colonic diseases. Sareen R; Jain N; Pandit V Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171 [TBL] [Abstract][Full Text] [Related]
22. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review. Hani U; Shivakumar HG Curr Drug Deliv; 2014; 11(6):792-804. PubMed ID: 25176028 [TBL] [Abstract][Full Text] [Related]
23. Curcumin marinosomes as promising nano-drug delivery system for lung cancer. Ibrahim S; Tagami T; Kishi T; Ozeki T Int J Pharm; 2018 Apr; 540(1-2):40-49. PubMed ID: 29408473 [TBL] [Abstract][Full Text] [Related]
24. Curcumin and Melanoma: From Chemistry to Medicine. Nabavi SM; Russo GL; Tedesco I; Daglia M; Orhan IE; Nabavi SF; Bishayee A; Nagulapalli Venkata KC; Abdollahi M; Hajheydari Z Nutr Cancer; 2018; 70(2):164-175. PubMed ID: 29300102 [TBL] [Abstract][Full Text] [Related]
25. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
27. In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: Curcumin therapeutic potential. Akbar MU; Zia KM; Akash MSH; Nazir A; Zuber M; Ibrahim M Int J Biol Macromol; 2018 Dec; 120(Pt B):2418-2430. PubMed ID: 30195611 [TBL] [Abstract][Full Text] [Related]
28. Curcumin and its formulations: potential anti-cancer agents. Ji JL; Huang XF; Zhu HL Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005 [TBL] [Abstract][Full Text] [Related]
29. Conundrum and therapeutic potential of curcumin in drug delivery. Kumar A; Ahuja A; Ali J; Baboota S Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240 [TBL] [Abstract][Full Text] [Related]
30. Curcumin-cyclodextrin complexes enhanced the anti-cancer effects of curcumin. Zhang L; Man S; Qiu H; Liu Z; Zhang M; Ma L; Gao W Environ Toxicol Pharmacol; 2016 Dec; 48():31-38. PubMed ID: 27716533 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability. Shelma R; Sharma CP Carbohydr Polym; 2013 Jun; 95(1):441-8. PubMed ID: 23618291 [TBL] [Abstract][Full Text] [Related]
32. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Ahsan H; Parveen N; Khan NU; Hadi SM Chem Biol Interact; 1999 Jul; 121(2):161-75. PubMed ID: 10418962 [TBL] [Abstract][Full Text] [Related]
33. Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks. Zhang Y; Rauf Khan A; Fu M; Zhai Y; Ji J; Bobrovskaya L; Zhai G J Drug Target; 2019 Nov; 27(9):917-931. PubMed ID: 30672353 [TBL] [Abstract][Full Text] [Related]
34. Transdermal delivery of the in situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment. Sun Y; Du L; Liu Y; Li X; Li M; Jin Y; Qian X Int J Pharm; 2014 Jul; 469(1):31-9. PubMed ID: 24746691 [TBL] [Abstract][Full Text] [Related]
35. Curcumin and curcumin-like molecules: from spice to drugs. Marchiani A; Rozzo C; Fadda A; Delogu G; Ruzza P Curr Med Chem; 2014; 21(2):204-22. PubMed ID: 23590716 [TBL] [Abstract][Full Text] [Related]
36. Preparation and evaluation of curcumin-loaded self-assembled micelles. Wang LL; He DD; Wang SX; Dai YH; Ju JM; Zhao CL Drug Dev Ind Pharm; 2018 Apr; 44(4):563-569. PubMed ID: 29148846 [TBL] [Abstract][Full Text] [Related]
37. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma. Luthra PM; Lal N Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of epithelial transport and oxidative stress protection of nanoengineered curcumin derivative-cyclodextrin formulation for ocular delivery. Maharjan P; Jin M; Kim D; Yang J; Maharjan A; Shin MC; Cho KH; Kim MS; Min KA Arch Pharm Res; 2019 Oct; 42(10):909-925. PubMed ID: 31030375 [TBL] [Abstract][Full Text] [Related]
39. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Doktorovova S; Souto EB; Silva AM Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267 [TBL] [Abstract][Full Text] [Related]
40. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth. Naksuriya O; Shi Y; van Nostrum CF; Anuchapreeda S; Hennink WE; Okonogi S Eur J Pharm Biopharm; 2015 Aug; 94():501-12. PubMed ID: 26134273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]